Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/MI/Kalamazoo
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Kalamazoo, MI

Studies commonly pay $75 to $4,500 per completed study

107 clinical trials are currently recruiting participants within 30 miles of Kalamazoo. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

107studies recruiting
7+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Kalamazoo right now

Top 25 of 107 recruiting studies, sorted by proximity — each links to its official registry page

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: National Cancer Institute (NCI)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: National Cancer Institute (NCI)

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma Phase 3 Interventional 510 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: SWOG Cancer Research Network

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8 Phase 3 Interventional 474 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: NRG Oncology

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

High Grade Osteosarcoma, Localized Osteosarcoma Phase 2, Phase 3 Interventional 1,122 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: National Cancer Institute (NCI)

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor Phase 2 Interventional 256 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: Children's Oncology Group

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8 Phase 3 Interventional 486 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: NRG Oncology

A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia

Schizophrenia Phase 1 Interventional 64 participants sought
Western Michigan University — Kalamazoo, Michigan (1.2 mi) · Sponsor: Janssen Research & Development, LLC

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Cardiovascular Risk, Acute Myocardial Infarction (AMI) Phase 3 Interventional 10,000 participants sought
WMU Homer Stryker MD School of Medicine — Kalamazoo, Michigan (1.2 mi) · Sponsor: Novo Nordisk A/S

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

Focal Segmental Glomerulosclerosis Phase 3 Interventional 286 participants sought
Paragon Health Nephrology Center - Kalamazoo — Kalamazoo, Michigan (1.2 mi) · Sponsor: Boehringer Ingelheim

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
West Michigan Cancer Center — Kalamazoo, Michigan (1.2 mi) · Sponsor: National Cancer Institute (NCI)

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Phase 3 Interventional 94 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: SWOG Cancer Research Network

Mobile Health for Adherence in Breast Cancer Patients

Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma N/A Interventional 410 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 1,524 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Lung Non-Small Cell Carcinoma Phase 2 Interventional 88 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: SWOG Cancer Research Network

Quality of End-of-Life Care for Children With Cancer

Childhood Hematopoietic and Lymphatic System Neoplasm, Childhood Malignant Solid Neoplasm N/A Observational 2,425 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: Children's Oncology Group

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 247 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: National Cancer Institute (NCI)

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Phase 1, Phase 2 Interventional 960 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: PedAL BCU, LLC

Transcutaneous Electrical Stimulation and Controlled Heat in People With and Without Diabetes

Diabetes, Heat N/A Interventional 20 participants sought
Western Michigan University — Kalamazoo, Michigan (1.2 mi) · Sponsor: Western Michigan University

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Acute Myeloid Leukemia Phase 3 Interventional 1,186 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: Children's Oncology Group

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

Stage I Mixed Cell Type Kidney Wilms Tumor, Stage II Mixed Cell Type Kidney Wilms Tumor Phase 3 Interventional 1,656 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: Children's Oncology Group

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma Phase 3 Interventional 360 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: National Cancer Institute (NCI)

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Cardiovascular Disease and Lipoprotein(a) Phase 3 Interventional 5,700 participants sought
Western Michigan University — Kalamazoo, Michigan (1.2 mi) · Sponsor: Novartis Pharmaceuticals
Actively enrolling

Studies you may be able to join near Kalamazoo

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Kalamazoo

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Center for Clinical Research at WMed

★ 5.0 (1 reviews)
1000 Oakland Dr, Kalamazoo, MI 49008
(269) 337-4264
"I would like overnight clinic study paid. Kalamazoo"
— Terri Dee Little, 5★

Center For Clinical Research Solutions

★ 5.0
321 S Kalamazoo Mall #214, Kalamazoo, MI 49007
(269) 488-5947

West Michigan Cancer Center

★ 4.9 (1299 reviews)
200 N Park St, Kalamazoo, MI 49007
(269) 382-2500
"Individuals that work here are informative and care about their patients."
— Kenneth Randt, 5★

West Michigan Clinical Research Center

2093 Health Dr SW Ste 201, Wyoming, MI 49519
(616) 328-5344

WMed Innovation Center

★ 5.0
4717 Campus Dr, Kalamazoo, MI 49008
(269) 353-1823

Lighthouse Autism Center - Kalamazoo

★ 3.3 (8 reviews)
4625 W KL Ave, Kalamazoo, MI 49006
(269) 249-1490
"Lighthouse helped my child be comfortable with herself and offered her support and fun ways to tackle challenges. The staff are all wonderful and de…"
— Angel Raatz, 5★

Kalamazoo Autism Center

★ 4.5 (8 reviews)
4200 S Westnedge Ave, Kalamazoo, MI 49008
(269) 459-7821
"My son attended the autism center for 2 years. During that time I cannot recall one issue with the Kalamazoo Autism Center. This was the most seamles…"
— Kyria, 5★

Clinical trials in Kalamazoo: what's recruiting

The Kalamazoo area currently has 107 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Kalamazoo, the most active research areas are:

  • Cancer & Oncology18 studies
  • Liver & Kidney2 studies
  • Heart & Vascular2 studies
  • Brain & Mental Health1 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Kalamazoo, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Kalamazoo

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Kalamazoo participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Kalamazoo pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Kalamazoo safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Kalamazoo, MI?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Kalamazoo?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Kalamazoo typically complete one or two studies per year.

Paid clinical trials near Kalamazoo

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of MI

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts